Colorectal cancer is thought to originate in colorectal adenoma and endoscopic polypectomy may prove prophylactic. To clarify the natural history of colorectal adenoma and the potential effects of endoscopic polypectomy, we retrospectively studied cohort patients undergoing full colonoscopies at 14 hospitals in Aomori Prefecture between January 1972 and December 1985. Subjects were divided into 3,574 non-adenoma controls and 1,020 adenoma patients, including 530 treated by polypectomy at initial examination. Subjects were followed up until the end of 1987 through record linkage with Aomori Colorectal Cancer Registry files to observe colorectal cancer occurrence. The ratio of observed number/expected number in the general population (O/E ratio) was 0.70 for the adenoma group and 0.36 for controls. The adenoma group was subdivided into polypectomy and non-polypectomy subgroups, with the O/E ratios of 0.39 for polypectomy patients and 0.75 for non-polypectomy patients. The O/E ratio in the adenoma group was about twice in controls, and this ratio in the nonpolypectomy subgroup was also about twice in thepolypectomy subgroup. The results suggest that colorectal adenoma provides a precancerous lesion that can be treated prophylactically by endoscopic polypectomy.
Download full-text PDF |
Source |
---|
Discov Oncol
January 2025
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Introduction: Colorectal cancer (CRC) is the second most common cause of cancer-related deaths globally. The gut microbiota, along with adenomatous polyps (AP), has emerged as a plausible contributor to CRC progression. This study aimed to scrutinize the impact of the FadA antigen derived from Fusobacterium nucleatum on the expression levels of the ANXA2 ceRNA network and assess its relevance to CRC advancement.
View Article and Find Full Text PDFColorectal Dis
January 2025
Department of Surgery, NHS Lanarkshire, Lanarkshire, UK.
Aim: The aim of this work was to quantify post-colonoscopy colorectal cancer (PCCRC) rates in National Health Service (NHS) Scotland using World Endoscopy Association guidelines, compare incidence between health boards and referral streams and explore comparisons in results with published data from other healthcare systems.
Method: This is a population-based cohort study using NHS Scotland data between 2012 and 2018. All people undergoing colonoscopy between 2012 and 2018 and subsequently diagnosed as having bowel cancer up to 3 years after their investigation were included.
Transl Cancer Res
December 2024
Department of Anorectal Surgery, the Second Hospital of Tianjin Medical University, Tianjin, China.
Background: Early detection for colorectal cancer (CRC) can enhance the patient prognosis. We aimed to validate the combined multi-gene detection in plasma of , , , and for early diagnosing of CRC in this prospective study.
Methods: Overall, 124 participants including 45 CRC patients, 8 advanced adenoma patients, 34 small polyp patients, and 37 normal controls who underwent colonoscopy were enrolled.
J Gastrointest Oncol
December 2024
Department of Internal Medicine, HCA Healthcare/USF Morsani College of Medicine GME, HCA Florida Blake Hospital, Bradenton, FL, USA.
Background: Colorectal cancer (CRC) causes substantial morbidity and mortality internationally. In Hungary, the incidence and mortality of CRC are among the world's highest. Fortunately, CRC is a highly preventable disease, since there is a long asymptomatic phase before neoplastic transformation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!